₹2,047.6
▼ -3.49 -0.17%
As of 23 Oct 2026 · delayed
NSE Listed
Corona Remedies Limited (CORONA)
Volume: 34,975Avg Vol 1W: 42,421.6Avg Vol 1M: 26,345.552W Range:₹1,336.6₹2,292.4
Key Ratios
Checked 5h agoMarket Cap₹12,545 Cr
Current Price₹2,047.6
Previous Close₹2,051.09
High / Low (52w)₹2,292.4 / ₹1,336.6
Volume34,975
Avg Vol (1W)42,421.6
Avg Vol (1M)26,345.5
Stock P/E59.11
Book Value₹122.12
Dividend Yield49%
ROE24.79%
ROA16.52%
Revenue (TTM)₹1,414 Cr
Revenue Growth17.9%
Profit Margin13.46%
Total Debt₹16 Cr
Shares Outstanding6 Cr
Face Value₹10
EPS (TTM)₹34.7
P/B16.83
Debt / Equity0.19
50 DMA₹2,098.11
200 DMA₹1,822.52
Day change-0.17%
Price Chart
₹2,047.6▲ 42.35% · 1Y
2025-12-152026-10-23
20-day avg volume: 26K shares
Pros
- Healthy return on equity of 24.8%.
- Pays a dividend yield of 49.0%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 59.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹314 Cr | ₹298 Cr | ₹294 Cr | ₹347 Cr | ₹361 Cr | ₹342 Cr | ₹353 Cr | ₹422 Cr |
| EBITDA | ₹60 Cr | ₹60 Cr | ₹46 Cr | ₹63 Cr | ₹72 Cr | ₹76 Cr | ₹56 Cr | ₹83 Cr |
| Net Profit | ₹43 Cr | ₹45 Cr | ₹32 Cr | ₹46 Cr | ₹52 Cr | ₹41 Cr | ₹45 Cr | ₹60 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,202 Cr | ₹294 Cr | ₹347 Cr | ₹361 Cr | ₹342 Cr | ₹353 Cr | ₹1,414 Cr | ₹422 Cr |
| EBITDA | ₹209 Cr | ₹46 Cr | ₹63 Cr | ₹72 Cr | ₹76 Cr | ₹56 Cr | ₹266 Cr | ₹83 Cr |
| Net Profit | ₹149 Cr | ₹31 Cr | ₹46 Cr | ₹52 Cr | ₹41 Cr | ₹45 Cr | ₹185 Cr | ₹60 Cr |
| EPS | 24.43 | — | — | — | — | — | 30.27 | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Total Assets | ₹396 Cr | ₹511 Cr | ₹595 Cr | ₹831 Cr | ₹930 Cr | ₹1,205 Cr |
| Total Liabilities | ₹127 Cr | ₹190 Cr | ₹187 Cr | ₹350 Cr | ₹324 Cr | ₹458 Cr |
| Equity | ₹269 Cr | ₹321 Cr | ₹409 Cr | ₹480 Cr | ₹606 Cr | ₹747 Cr |
| Total Debt | ₹18 Cr | ₹17 Cr | — | — | — | — |
Cash Flow
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | ₹99 Cr | ₹129 Cr | ₹175 Cr | ₹234 Cr | ₹279 Cr |
| Investing | ₹-66 Cr | ₹-50 Cr | ₹-267 Cr | ₹-84 Cr | ₹-256 Cr |
| Financing | ₹-30 Cr | ₹-45 Cr | ₹99 Cr | ₹-107 Cr | ₹25 Cr |
| Free Cash Flow | ₹99 Cr | ₹129 Cr | ₹175 Cr | ₹234 Cr | ₹279 Cr |
Shareholding
Promoter 69% Institutions 20.66% Public 10.34%
Efficiency & Working Capital
ROCE27.1%
Interest Coverage35.5
Dividend Payout—
Debtor Days38 d
Inventory Days33 d
Payable Days38 d
Cash Conversion Cycle32 d
Working Capital Days70 d
Shareholding Details
As of 2026-09-30
Promoter69%
FII4.2%
DII16.5%
Institutions20.7%
Public10.3%
Promoter Pledge0%
No. of Shareholders21,098
Shareholding Pattern
Quarterly — figures in %. Latest 6 quarters.
| Period | Apr 2025 | Apr 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|
| Promoters | 72.5% | 72.5% | 69% | 69% | 69% | 69% |
| FIIs | 0% | 0% | 1.8% | 2.2% | 3.6% | 4.2% |
| DIIs | 27.5% | 0% | 6.8% | 7% | 12.9% | 16.5% |
| Public | 0% | 27.5% | 22.4% | 21.7% | 14.5% | 10.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9 | 9 | 31,035 | 19,609 | 20,185 | 21,098 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ankurbhai K Mehta | Shareholding of Promoter and Promoter Group | 22% | 1.35 Cr |
| Nirav Kirtikumar Mehta | Shareholding of Promoter and Promoter Group | 22% | 1.35 Cr |
| Kirtikumar Laxmidas Mehta | Shareholding of Promoter and Promoter Group | 20% | 1.22 Cr |
| Sepia Investments Limited | Public Shareholding | 8.6% | 52,70,310 |
| Invesco India Small Cap Fund | Public Shareholding | 5.3% | 32,16,803 |
| Hdfc Trustee Company Limited-hdfc Flexi Cap Fund | Public Shareholding | 4.1% | 25,06,683 |
| Sbi Retirement Benefit Fund- Conservative Plan | Public Shareholding | 3.6% | 21,80,360 |
| Dipaben Niravkumar Mehta | Shareholding of Promoter and Promoter Group | 2% | 12,22,047 |
| Brinda Ankur Mehta | Shareholding of Promoter and Promoter Group | 2% | 12,22,047 |
| Minaxi Kirtikumar Mehta | Shareholding of Promoter and Promoter Group | 1% | 6,08,567 |
| Hetvi Nirav Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vanshaj Niravkumar Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Jitendrakumar Champaklal Vora | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Chandrika Jitendrakumar Vora | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Nehal Devang Vora | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Heti Darshan Kothari | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vishwa Ankur Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Jainam Ankur Mehta | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Subodhbhai Vrajlal Parikh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shardaben Subodhbhai Parikh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pritesh Subodhbhai Parikh | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kanakben Arvindbhai Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Yogeshbhai Harilal Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ketan Harilal Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Nemish Harilal Shah | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| KIRTIKUMAR LAXMIDAS MEHTA | Chairman(Non Exe)&Dir(Non-Ind) | 2026 |
| NIRAVKUMAR KIRTIKUMAR MEHTA | ED / MD / CEO / Promoter | 2026 |
| ANKUR KIRTIKUMAR MEHTA | ED / Joint MD / Promoter | 2026 |
| VIRAL BHUPENDRABHAI SITWALA | E D & Wholetime Director | 2026 |
| Ameet Desai | Independent Non Exe. Director | 2026 |
| Monica Kanuga | Independent Non Exe. Director | 2026 |
| Shirish Gundopant Belapure | Independent Non Exe. Director | 2026 |
| Bhaskar Vemban Iyer | Independent Non Exe. Director | 2026 |
| Chetna Darajiya | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| In India | ₹1,152 Cr | 96.3% |
| Outside India | ₹44 Cr | 3.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 61 | 61 | 61 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-31 | Board Meetings | — |
| dividend | 2026-06-19 | ₹10.0 (100.0%) | Final |
| dividend | 2026-06-19 | ₹10 (100%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 5 | 0 | 12 | 2 | 21 |
| 2026 | 0 | 0 | 0 | 1 | 0 | 4 |
| 2026 | 0 | 5 | 0 | 10 | 2 | 18 |
Insider / Designated-Person Trades
14 recent disclosure(s)
Ranjanben Kirtisinh ParmarAcquisition · 75
Ranjanben Kirtisinh ParmarAcquisition · 90
Kirtisinh Manoharsinh ParmarAcquisition · 43
Kirtisinh Manoharsinh ParmarAcquisition · 2
Kirtisinh Manoharsinh ParmarAcquisition · 50
Kirtisinh Manoharsinh ParmarAcquisition · 1
Company Information
Incorporated2004
ChairmanKIRTIKUMAR LAXMIDAS MEHTA
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
📍 Corona House C-Mondeal Busines, #NAME?, Ahmedabad, Gujarat, 380059
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Cool Caps Industries Ltd.Coral India Finance & Housing Ltd.Waterways Leisure Tourism LimitedCords Cable Industries Ltd.Coreintegra Consulting Services Ltd.Coromandel International Ltd.Cosmo First LimitedCountry Condo S LimitedCP Capital LimitedCareer Point Edutech Ltd.Captain Polyplast LimitedAditya Infotech LimitedAll “C” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search